Pfizer brags of pipeline, refocuses R&D
Matthew Arnold
October 02 2008
Pfizer announced that the number of compounds it has in Phase 3 development has grown from 16 to 25 over ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.